Novartis India Ltd.

NOVARTIND

₹1156.0

1.56% (17.75)

Market Cap

₹2,854 Cr.

P/E

33.50

About

Novartis India Limited is a pharmaceutical company with operations in Pharmaceuticals, Generics, over the counter (OTC) products, and Animal Health. The company provides prescription medicines through… Read more

Novartis India Limited is a pharmaceutical company with operations in Pharmaceuticals, Generic… Read more

Low

600

52W Range

High

1224

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

11.44%

3yr Average

8.08%

5yr Average

5.71%

Net Profit Margin

Latest

25.42%

3yr Average

17.26%

5yr Average

11.91%

ROCE

Latest

8.51%

3yr Average

6.03%

5yr Average

4.99%

Debt to Equity

Latest

0.0

3yr Average

0.0

5yr Average

0.0

Market Share

1.80 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.06 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.09 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.14 %

(as of May 19)

Historic

Blood Related - Market Share

0.72 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.03 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.01 %

(as of Aug 18)

Historic

Endocrinology - Market Share

0 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.85 %

(as of Nov 21)

Historic

Gynecology - Market Share

0.51 %

(as of Nov 21)

Historic

Neurological - Market Share

6.46 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

2.40 %

(as of Nov 21)

Historic

Pain - Market Share

0.55 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.17 %

(as of Nov 21)

Historic

Respiratory - Market Share

0.43 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source

Peer Comparison

Brands

Voveran

Suppliers

Bharat Dynamics Ltd.
Aarti Industries Ltd.
Piramal Enterprises Ltd.
Navin Fluorine International Ltd.
Neuland Laboratories Ltd.
EPL Ltd.
Morepen Laboratories Ltd.
Allcargo Gati Ltd.
Gulshan Polyols Ltd.
Kilitch Drugs (India) Ltd.
Take Solutions Ltd.
Hindusthan National Glass & Industries Ltd.
Vivimed Labs Ltd.

Showing 5 of 13

FAQs on Novartis India Ltd. Business

What does Novartis do?

Novartis India Limited operates in pharmaceuticals, generics, over the counter (OTC), and animal health segments. It provides prescription medicines, retail generic products, and products for cattle and poultry markets.

Who are the competitors of Novartis?

Novartis major competitors are Indoco Remedies, Sequent Scientific, Gufic Biosciences, Guj. Themis Biosyn, Unichem Lab, Zota Health Care, Syncom Formulations.
Market Cap of Novartis is ₹2,854 Crs.
While the median market cap of its peers are ₹3,505 Crs.

Is Novartis financially stable compared to its peers?

Novartis seems to be less financially stable compared to its peers.
Altman Z score of Novartis is 2.62 and is ranked 8 out of its 8 competitors.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec